6 month order of tyvaso 0.6MG/ML refill kit

Ended Awarded Last action

Contract number
36C26322N0207
Awardee
Awarding agency
Obligated
$75,656

Award facts

Contract value 100% obligated
$75,656.34 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20910, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$78
Funding Only Action P00001 $5,764
Original award $69,971

About this award

This is a $75,656.34 firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for a 6-month supply of Tyvaso (treprostinil) 0.6mg/mL inhalation solution refill kits. This delivery order is placed against United Therapeutics' $50 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center for the supply of its pulmonary arterial hypertension and oncology drug portfolio, including Orenitram, Remodulin, Tyvaso, and Unituxin. United Therapeutics also holds a $198 million Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs, enabling the agency to centrally source the company's entire medication offerings. These Indefinite Delivery Vehicles, valued up to $250 million combined, facilitate the VA's distribution of critical treatments to its integrated healthcare networks nationwide. No set-aside designation was used for this commercial item procurement.

Quick answers

Who was awarded contract 36C26322N0207?

36C26322N0207 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 23 (Veterans Health Administration) on October 26, 2021.

How much is contract 36C26322N0207 worth?

The government has obligated $75,656 on 36C26322N0207.

Is contract 36C26322N0207 an order under another contract?

Yes. 36C26322N0207 is a BPA call under 36F79720D0104-36E79720A0008, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26322N0207 competed?

The extent of competition for 36C26322N0207 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award